Abstract
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that it will soon launch a public consultation on changes to the UK legal framework for clinical trials, which could result in greater transparency and increase patient involvement. The consultation, which the MHRA confirmed was imminent to The Pharmaceutical Journal on 12 January 2022, may […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
